New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
05:32 EDTBAYRY, REGNRegeneron Eylea injection receives EU approval for DME treatment
Regeneron Pharmaceuticals (REGN) announced that Eylea Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema, or DME. Bayer Healthcare (BAYRY) plans to launch Eylea in DME in the EU this quarter. Bayer HealthCare and Regeneron are collaborating on the global development of Eylea.
News For REGN;BAYRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
05:25 EDTBAYRY, REGNRegeneron reports approval of Eylea by Japan
Subscribe for More Information
June 25, 2015
14:01 EDTBAYRYBayer initiated with a Buy at HSBC
Subscribe for More Information
08:00 EDTBAYRYBayer to hold a meeting
Subscribe for More Information
June 23, 2015
10:31 EDTBAYRYMonsanto says Bayer crop chemicals unit an option, Bloomberg reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use